EKF Diagnostics Holdings Plc - Asset Resilience Ratio

Latest as of December 2024: -1.58%

EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of EKF Diagnostics Holdings Plc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX-1.29 Million
≈ $-156.83 USD Cash + Short-term Investments

Total Assets

GBX81.75 Million
≈ $9.95K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EKF total assets.

Liquid Assets Composition Over Time

This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore EKF Diagnostics Holdings Plc (EKF) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX-1.29 Million -1.58%
Total Liquid Assets GBX-1.29 Million -1.58%

Asset Resilience Insights

  • Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio

Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Epitomee Medical Ltd
TA:EPIT
Medical Devices 0.24%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%

Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)

The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 -1.58% GBX-1.29 Million
≈ $-156.83
GBX81.75 Million
≈ $9.95K
-1.66pp
2011-12-31 0.09% GBX51.00K
≈ $6.21
GBX58.73 Million
≈ $7.15K
-0.19pp
2010-12-31 0.28% GBX100.00K
≈ $12.17
GBX35.98 Million
≈ $4.38K
-7.12pp
2009-12-31 7.39% GBX473.00K
≈ $57.55
GBX6.40 Million
≈ $778.33
--
pp = percentage points

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.30 Million
GBX10.70 Billion GBX
Market Cap Rank
#30506 Global
#765 in UK
Share Price
GBX25.00
Change (1 day)
+0.00%
52-Week Range
GBX21.80 - GBX31.00
All Time High
GBX78.21
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more